Company intelligence / Profile preview

Glaucot Teknoloji Anonim Sirketi

Istanbul, Istanbul Province, Turkeylinkedin.com ↗

Ownership: Private
Employees: ~4
Development stage: Preclinical

Overview

GlaucoT has developed a noninvasive, home-use wearable device that delivers gamma rhythm stimulation to reduce neuroinflammation associated with glaucoma. The company’s approach aims to provide an alternative to medication or surgery for glaucoma patients. Early-stage patents have been granted, and the company is currently at the seed funding stage with ongoing development and validation of its technology

Therapeutic areas: Ophthalmology
Modalities: Device (wearable tech for gamma rhythm stimulation)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

GlaucoT

Pre-clinical

Indications: Glaucoma

Partnerships

BIO Startup Program (investor/partner)Alesta YatirimGeometry VentureErol Teberoglu

Beyond the preview

Go deeper on Glaucot Teknoloji Anonim Sirketi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glaucot Teknoloji Anonim Sirketi.

Explore the full profile